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ABSTRACT
Preventive effects of two traditional Chinese medicines, Chia-wei-hsiao-yao-san and Kuei-lu-erh-hsien-chiao, on the bone loss
induced by ovariectomy in Long-Evans rats were investigated. The rats were divided randomly into five groups. The first group was
given a sham operation with administration of distilled water, whereas the second, third and fourth groups were ovariectomized with
administration of distilled water, Kuei-lu-erh-hsien-chiao and Chia-wei-hsiao-yao-san, respectively. The rats of the fifth group were
embedded by intraperitoneal with a silicon tube containing 17 β-estradiol (10% in cholesterol) at a dose of 10 µg/kg. Eight weeks later,
the mean differences of spinal bone mineral density (BMD) in groups 1, 4 and 5 were significantly higher than that in group 2. The
mean differences of plasma alkaline phosphatase (ALP) in groups 1 and 5 were significantly lower than those in group 2, but there were
no significant differences between groups 1 and 5. In histologic analysis, the cross sections from lower third of the tibial shaft in group
3 showed more mucopolysaccharide accumulation than those in groups 4 and 5. The urinary N-telopeptide of type I collagen (NTx)
levels did not differ significantly among groups 1, 2, 3, 4 and 5. Nevertheless, the mean differences of urinary deoxypyridinoline (Dpd)
levels in group 5 were significantly higher than those in group 2. 17 β-estradiol and Chia-wei-hsiao-yao-san showed more profound
effect than Kuei-lu-erh-hsien-chiao in the prevention of bone loss in the ovariectomized (OVX) rats. Although 17 β-estradiol exerted
more profound effect, Chia-wei-hsiao-yao-san showed good compliance and safety for relief of climacteric symptoms for postmenopausal women in a previous study. Therefore, Chia-wei-hsiao-yao-san might be an alternative for preventing bone loss.
Key words: 17 β-estradiol, Chia-wei-hsiao-yao-san, Kuei-lu-erh-hsien-chiao, ovariectomized, osteoporosis

INTRODUCTION
Estrogen has long been touted as a beneficial factor in
preventing bone loss in premenopausal women. Women
who were menopausal or received the oophoreectomy lose
this protection because of dramatic decreases in estrogen
levels due to natural atrophy of the ovaries(1,2) or surgical
deprivation of the ovaries. Bone mass decreases significantly during the postmenopausal (3) and surgical
menopausal states. The ovariectomized rat model is used to
mimic the trabecular bone loss observed in the postmenopausal and surgical menopausal states(4).
Estrogen replacement therapy in postmenopausal and
surgical menopausal women restores the protective actions
* Author for correspondence. Tel: +886-7-3121101 ext. 7262;
Fax: +886-7-2370544; E-mail: tsliyu@kmu.edu.tw
The first two authors contributed equally to this work.

against bone loss(5,6). However, this treatment has several
side effects, such as increased risk of breast cancer and
resumption of menses(7,8). Chia-wei-hsiao-yao-san was
used as a safe and efficacious therapy that might be an
alternative for relief of climacteric symptoms in postmenopausal women who refuse or have contraindications
for hormone replacement therapy(9). Chia-wei-hsiao-yaosan and Kuei-lu-erh-hsien-chiao have been reevaluated by
clinicians (10,11) . According to the traditional Chinese
medicines, bone loss is categorized as bone wilting, vacuity
taxation or lumbar pain and the kidney governs the bone
and engenders bone and marrow. These illustrate the close
relationship between the kidney and the bone. Kuei-lu-erhhsien-chiao includes Testudinis Plastrum, Cervi Cornu,
Lycii Fructus and Ginseng Radix. Testudinis Plastrum and
Cervi Cornu are collagen-rich materials, and Testudinis
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Plastrum is believed to enhance physical activity and to
promote the function of kidney(12). The formula of Chiawei-hsiao-yao-san contains Angelicae Radix, Atractylodis
Rhizoma, Paeoniae Radix, Bupleuri Radix, Hoelen,
Glycyrrhizae Radix, Moutan Cortex, Gardeniac Fructus,
Zingiberis Sieatum Rhizoma and Menthae Herba. Chiawei-hsiao-yao-san is used to treat gynecological diseases
and postmenopausal symptoms(9), such as severe flushes,
insomnia, muscle aches and pains, formication, fatigue, palpitations and mood swings. It also exerts beneficial effect
on the premenstrual tension syndrome, and is a novel
formula for hypofunction of the reproductive system(13,14).
The effectiveness of Chia-wei-hsiao-yao-san on repairing
the ovary function apparently correlates to the efficacy in
curing osteoporosis.
Measurement of Bone Mineral Density (BMD) for the
diagnosis of bone loss by computed X-ray densitometry
(CXD) method has been recognized(15), but the decrease of
BMD is not obvious in a short time interval(16,17). Alkaline
phosphatase (ALP) is a bone formation marker. In addition, other indicators of bone resorption, the deoxypyridinoline (Dpd) and N-telopeptide of Type I collagen (NTx)
in human urine have been used to evaluate the effect of
antiresorptive therapy on bone loss in postmenopausal
women(17-19). Bone formation markers and bone resorption markers are biomarkers of bone turnover rate.
In this study, we examined the effectiveness of Chiawei-hsiao-yao-san and Kuei-lu-erh-hsien-chiao on preventing the progress of bone loss induced by ovariectomy
in the rats.
Table 1. Herbal constituents and contents of Kuei-lu-erh-hsien-chiao
and Chia-wei-hsiao-yao-san
Contents (%, w/w)
Chia-wei-hsiao
Kuei-lu-erh
Herbs
-yao-san
-hsien-chiao
Angelicae Radix
12.1
Atractylodis Rhizoma
12.1
Paeoniae Radix
12.1
Bupleuri Radix
12.1
Hoelen
12.1
Glycyrrhizae Radix
6.1
Moutan Cortex
7.6
Gardeniac Fructus
7.6
Zingiberis Sieatum Rhizoma
12.1
Menthae Herba
6.1
Testudinis Plastrum
29.4
Cervi Cornu
58.8
Lycii Fructus
6.5
Ginseng Radix
5.3

Table 2. Classification and treatment of the experimental rats
Groups
n
1. (sham+D.W.)
6
2. (OVX+D.W.)
8
3. (OVX+ Kuei-lu-erh-hsien-chiao)
8
4. (OVX+ Chia-wei-hsiao-yao-san)
9
5. (OVX+ 17β-estradiol)
7

MATERIALS AND METHODS
I. Traditional Chinese Medicines and Chemicals
Herbal constituents and contents of Kuei-lu-erh-hsienchiao and Chia-wei-hsiao-yao-san refer to the Yi-Fang-JiJie(20). All materials of Kuei-lu-erh-hsien-chiao and Chiawei-hsiao-yao-san were extracted with water and filtered to
remove the insoluble debris. Then the extracts of Kuei-luerh-hsien-chiao and Chia-wei-hsiao-yao-san were concentrated 5.67 and 4.46 times to get the final products, respectively. Their herbal constituents and contents are shown in
Table 1. 17 β -estradiol was purchased from Sigma
Chemicals (St. Louis, MO, USA). All other reagents were
purchased from chemical companies.
II. Ovariectomy and Administration of Traditional Chinese
Medicines
Five- to six-week-old female Long-Evans rats with
body weight from 100-180 g were purchased from the
National Laboratory Animal Breeding and Research Center
(Taiwan). All rats were under regulated 12 hr/12 hr lightdark illumination cycles at constant temperature (24 ±
0.5˚C) and humidity (45-50%). The test subjects had free
access to standard chow. Body weight was measured at a
specified time during the course of the experiment. Seven
weeks later, the first mature rats model at 3 months old(3)
were used. They were divided randomly into five groups
(Table 2). The first group was given a sham operation,
while the second, third, fourth and fifth groups were
ovariectomized under nembutal (pentobarbital sodium; 50
mg/kg: Abbott Laboratories, IL) anesthesia. A small
midline dorsal skin incision (1-2 cm) was made just caudal
to the 13th rib. Bilateral ovariectomy was performed
according to the procedures described by Waynforth and
Flecknell(21). Simultaneously, the rats of the fifth group
were embedded with a silicon tube containing 17 β estradiol (10% in cholesterol) in intraperitoneal at a dose of
10 µg/kg. The silicon tube was refilled once a month for
eight weeks. The fourth group received Chia-wei-hsiaoyao-san (2.5 g/kg/day) via gastric gavage; the third group
received Kuei-lu-erh-hsien-chiao (2.5 g/kg/day), and the
first and second groups received distilled water during the
experimental period. The traditional Chinese medicines
were given daily for eight weeks, and each dose followed
the previous one after 24 hr. The total volume of solution
gavaged for each dose was controlled within 1 to 1.5 mL.

Operation
Sham
Ovariectomized
Ovariectomized
Ovariectomized
Ovariectomized

Treatment
Distilled water
Distilled water
Kuei-lu-erh-hsien-chiao
Chia-wei-hsiao-yao-san
17 β-estradiol
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III. Measurement of Bone Mineral Density (BMD)
BMD was quantitatively determined by the CXD
method (15) (HOLOGIC QDR TM 1500, Hologic INC,
Waltham, MA, USA) before operation and after termination. The rats were anesthetized prior to measurement.
The densitometry pattern of the lumbar spines on an X-ray
picture was read by a personal computer using a software
program for rat bone density. Bone mineral results were
reported for these regions by a BMD index.
IV. Histologic Analysis
Rats with pentobarbital were perfused with 2%
paraformaldehyde and 2% glutaraldehyde in 0.1 M
phosphate buffer (pH 1.4) through the left ventricle for 15
min. The tibiae were immediately extracted and immersed
in the same fixative for 3 days at 4˚C. The specimens were
decalcified with 10% EDTA solution for 3 days at 4˚C.
The samples were embedded in paraffin for histological
examination. The proximal tibial heads were transected,
and the cross sections from lower third of the tibial shaft
were made. All the sections were dehydrated by a stepwise application of 70 and 99.9% (v/v) ethanol solutions
and stained with hematoxylin and eosin(22).
V. Biochemical Analysis
Before the operation and eight weeks after the
operation, blood samples from the retro-orbital plexus were
taken from all rats. Heparin plasma was then separated by
centrifugation at 2,000 rpm for 10 min at 4˚C and analyzed
for ALP. Urine samples were collected for 24 hr in
metabolic cages at the same time. Urine samples were
tested for creatinine (CRTN), Dpd and NTx levels. The
assay values of urine were corrected for kidney function by
urinary CRTN levels. CRTN levels and ALP activity were
analyzed using Toshiba biochemical analyzer (TBA-80FR,
Tokyo, Japan). CRTN and ALP were tested by Jaffe-rate
method (seiken reagent kit, Tokyo, Japan) and BesseyLowry-Brock method (seiken reagent kit, Tokyo, Japan),
respectively.
Dpd values were analyzed using the METRA DPD
EIA Kit (Quidel Co., CA, USA) by an automated chemiluminescence system (ACS: 180®, Bayer, NY, USA). Dpd
assay is a competitive enzyme immunoassay in a microtiter
strip-well format utilizing a monoclonal anti-Dpd antibody
coated on the strip to capture Dpd. Dpd in the sample
competes with conjugated Dpd-alkaline phosphatase for the
antibody, and the reaction is detected with a pNPP
substrate. Dpd values must be corrected for variation in
urine concentration by dividing the Dpd value (nmol/L) by
the CRTN value (mmol/L). The final Dpd result is
expressed as nmol/mmol CRTN.
NTx assay was performed using the Vitros NTx
reagent pack (Ortho-Clinical Diagnostics, Amersham, UK)
and Vitros immunodiagnostic products NTx calibrators on

the Vitros Eci immunodiagnostic system. A competitive
immunoassay technique was used. NTx values are
corrected for urinary dilution by urinary CRTN analysis and
expressed in nanomoles bone collagen equivalents per liter
(nM BCE) per millimole CRTN per liter (mM creatinine).
VI. Statistics
Data were expressed as mean ± standard error. The
mean differences were calculated from the values subtracted by the baseline (pre-operation) from the values after 8
weeks of treatment after operation. The mean difference
level in group 2 was compared to those in groups 1, 3, 4,
and 5 using Wilcoxon’s Sum of Ranks test. When the probability was less than 0.05, the difference was considered
statistically significant.

RESULTS
I. Body Weight
As shown in Figure 1, 8 weeks after the ovariectomy,
the body weights in group 2 were significantly higher than
those in groups 1, 4 and 5. There were no significant differences in the body weights between groups 2 and 3. The
body weights of groups 4 and 5 were almost the same as
those of group 1.
II. Bone Mineral Density (BMD)
As shown in Figure 2A, the mean differences of
BMD levels in group 2 were significantly lower than those
in group 1 (p < 0.01). The mean differences of BMD in
groups 3, 4 and 5 were higher than those in group 2.
BMD significantly differed between groups 2 and 4 (p <
0.05) and between groups 2 and 5 (p < 0.01). However,
there was no significant difference between groups 2 and 3
(p > 0.05).
III. Plasma ALP Activity
The mean differences of ALP in groups 2, 3 and 4
were higher than those in groups 1 and 5. There were significant differences between groups 1 and 2. The mean difference of ALP in group 5 was significantly lower than that
in group 2 (Figure 2B).
IV. Urine Analysis
The mean differences of the Dpd levels in group 5
were higher than those in groups 1, 2, 3 and 4, and there
were significant differences between groups 2 and 5
(Figure 2C). However, there were no significant differences in urinary NTx levels among groups 1, 2, 3, 4 and 5
(Figure 2D).
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V. Histologic Analysis

b

(A)

On transections of the proximal tibial heads, the epiphyseal plates in groups 1 were more compact than those in
groups 4 and 5 (Figure 3A-C), but there were no obvious
differences among them. The cross sections from lower
third of the tibial shaft in group 3 showed more
mucopolysaccharide accumulations than those in groups 4
and 5 (Figure 3D-F).
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Hidaka et al. (23) strongly asserted that traditional
Chinese (Kampo) medicines, Unkei-to, Hachimi-jio-gan,
and Juzen-taiho-to were as effective as 17 β-estradiol in
preventing the development of bone loss induced by OVX
in rats for a period of 49 days. Therefore, we evaluated the
effectiveness of Chia-wei-hsiao-yao-san and Kuei-lu-erhhsien-chiao on bone loss induced by OVX in rats throughout 8 weeks.
Due to higher food consumption, fat and protein gain,
and food efficiency in the OVX rats(23,24), ovariectomy
caused an increase of their body weights (Figure 1). A gain
in weight was possibly a partial protection against the
development of osteoporosis in the long bone (25) .
Treatment of 17 β -estradiol or Chia-wei-hsiao-yao-san
almost abolished the OVX-induced obesity, which may be
corelated with the diuretic action of Paeoniae Radix and
Hoelen. However, Kuei-lu-erh-hsien-chiao cannot prevent
the OVX-induced obesity in this study.
Although our results indicated that the spinal BMD of
the OVX rats showed a small increase as compared to
previous studies(26,27), the mean differences of BMD levels
in group 2 were significantly lower than those in group 1
(p < 0.01). In humans, girls receiving oophoreectomy
during teen age continue to grow. Even so, the mean differences of BMD in groups 1, 3, 4 and 5 were higher than
those in group 2, and there were significant differences
between groups 1, 4, 5 and 2, respectively. The differences
between groups 1, 5 and 2 were more significant than
those between groups 4 and 2. Although the mean differ-

2

3

4

5

Group

Figure 1. The body weights of various groups 8 weeks after
operation.
a
The mean differences differed from those in group 2 were significant
(p < 0.05).

Figure 2. The mean differences of (A) BMD (gms/cm2), (B) plasma
ALP (IU/L), (C) urinary Dpd (nmol/mmol CRTN) and (D) urinary
NTX (nM BCE/mM CRTN) from the values that substracted the
baseline (pre-operation) from the analyzed values after 8 weeks of
treatment after the operation in various groups
a
The mean differences differed from those in group 2 were significant
(p < 0.05).
b
The mean differences differed from those in group 2 were significant
(p < 0.01).
c
The standard error of the mean differences.
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(A)

(B)

(C)

(D)

(E)

(F)

Figure 3. Histologic analysis of the epiphyseal plates (arrow) in the transections of the proximal tibial heads from groups 1 (A), group 5 (B)
and group 4 (C). Histologic analysis of mucopolysaccharide accumulations (arrow) in the cross sections of lower third of the tibial shaft from
group 5 (D), group 4 (E) and group 3 (F).
represent 100 µm.

ences of BMD in group 3 were higher than those in group
2, there were no significant differences between the two
groups. If the duration of the experiment is longer, there
might be significant difference between these two groups.
Losses of tibial cortical bone in human are seen in immobilization(28) and senile osteoporosis(29). Young et al.(30)
demonstrated that restraint in the semirecumbent position
produced regional losses of bone mostly in the anteriorproximal tibiae. Tibial bone showed lesions of whole
osteons after 4 weeks of restraint. The cement line of
osteons was partially replaced by what appears to be a substantial accumulation of mucopolysaccharide. In our
results, the epiphyseal plates in groups 1 was more
compact than those in groups 5 and 4, and that in group 5
was more compact than those in group 4. Nevertheless,
there were no obvious differences among them. The cross
sections from lower third of the tibial shaft in group 3
showed more mucopolysaccharide accumulations than
those in groups 4 and 5. Furthermore, the mucopolysaccharide accumulations in group 4 were more than those
in group 5. Therefore, Kuei-lu-erh-hsien-chiao is not as
effective as 17 β-estradiol or Chia-wei-hsiao-yao-san in
preventing bone loss. Moreover, 17 β-estradiol showed
more profound effect than Chia-wei-hsiao-yao-san.

Gala et al.(31) reported that OVX rats showed a significant decrease (p < 0.05) in BMD and a significant increase
in ALP with regard to their respective sham group.
Furthermore, Nawawi et al.(32) demonstrated that there
were significantly higher serum TALP (total alkaline phosphatase), BSALP (bone specific alkaline phosphatase) and
urinary Dpd levels in non-HRT (hormone replacement
therapy) treated patients compared to the controls. There
were no significant differences in the levels of above three
bone markers between the HRT treated patients and control
subjects. In our results, the plasma ALP levels significantly
decreased in groups 5 and 1. Although the plasma ALP
levels also decreased in groups 3 and 4, but there were no
significant differences between groups 3, 4 and 2, respectively. It was referred that the doses of Kuei-lu-erh-hsienchiao and Chia-wei-hsiao-yao-san might be lower than the
effective dose. Although the BSALP activity was more
specific than the TALP activity as bone marker, the BSALP
activity was not detectable in rats.
Both bone resorption and bone formation are
promoted by the ovariectomy, and the prominent increase
of the bone resorption is known as high-turnover osteoporsis(33). Urinary NTx and Dpd are bone resorption markers,
whereas serum ALP and osteocalcin are bone formation
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markers. In our results, there was a significantly negative
correlation between plasma ALP activity and BMD in the
OVX rats (data not shown), but there was no significant
correlation between urinary Dpd or urinary NTx levels and
BMD (data not shown). In contrast to previous
reports (31,34,35) , Frolik et al. (36) showed that ethynyl
estradiol lowered serum ostecalcin level within 1 week of
treatment by 18%, with a more pronounced reduction of
34% at 3 weeks in OVX rats. Urinary Dpd level was
reduced with time. Swaminathan (37) demonstrated that
urinary Dpd levels showed diurnal variation, the individual
variation was large, and BSALP was much more stable and
less variant within each test subjects. We cannot infer to
the BMD levels by the urinary Dpd or NTx determination,
but they can provide us with an early index of the degree of
bone resorption. As the result, some protective strategies
can be performed in time.
We conclude that Kuei-lu-erh-hsien-chiao (2.5
g/kg/day) cannot prevent bone loss induced by ovariectomy
in rats, but 17 β-estradiol (10 µg/kg) and Chia-wei-hsiaoyao-san (2.5 g/kg/day) have beneficial effects in preventing
bone loss in the OVX rats. Although 17 β-estradiol showed
more profound effect than Chia-wei-hsiao-yao-san, the beneficial effects of Chia-wei-hsiao-yao-san were not mediated
by hormone replacement. Chia-wei-hsiao-yao-san showed
good compliance and safety for relief of climacteric
symptoms in postmenopausal women(9). Therefore, Chiawei-hsiao-yao-san might be an alternative choice for preventing bone loss.

ACKNOWLEDGEMENTS
The study was supported by the research grant from
the National Science Council, Executive Yuan, Taiwan,
ROC (NSC89-2314-B-037-090). We would also like to
thank the Chuang Song Zong Pharmaceutical Company,
Kaohsiung, Taiwan, for donating the traditional Chinese
medicines, Kuei-lu-erh-hsien-chiao and Chia-wei-hsiaoyao-san.

REFERENCES
1. Robinson, R. W., Higanov, N. and Cohen, W. D. 1959.
Increased incidence of coronary heart disease in women
castrated prior to the menopause. Arch. Intern. Med.
104: 908-913.
2. Rosenberg, L., Hennekens, C. H., Rosner, B., Belanger,
C., Rothman, K. J. and Speizer, F. E. 1981. Early
menopause and the risk of myocardial infarction. Am.
J. Obstet. Gynecol. 139: 47-51.
3. Albright, F., Smith, P. H. and Richardson, A. M. 1941.
Postmenopausal osteoporosis: its clinical features. J.
Am. Med. Assoc. 116: 2465-2474.
4. Wronski, T. J. and Yen, C. F. 1991. The ovariectomized
rat model as an animal model for postmenopausal bone

loss. Cells Mater. Suppl. 1: 69-74.
5. Ettinger, B., Genant, H. K. and Cann, C. E. 1987.
Postmenopausal bone loss is prevented by treatment
with low-dosage estrogen with calcium. Ann. Intern.
Med. 106: 40-45.
6. Barrett-Connor, E., Young, R., Notelovitz, M., Sullivan,
J., Wiita, B., Yang, H. M. and Nolan, J. 1999. A twoyear, double-blind comparison of estrogen-androgen
and conjugated estrogens in surgically menopausal
women. Effects on bone mineral density, symptoms and
lipid profiles. J. Reprod. Med. 44: 1012-1020.
7. Judd, H. L., Meldrum, D. R., Deftos, L. J. and
Henderson, B. E. 1983. Estrogen replacement therapy:
indications and complications. Ann. Intern. Med. 98:
195-205.
8. Henderson, B. E., Ross, R. K. and Pike, M. C. 1983.
Hormonal chemoprevention of cancer in women.
Science 259: 633-638.
9. Chen, L. C., Tsao, Y. T., Yen, K. Y., Chen, Y. F., Chou,
M. H. and Lin, M. F. 2003. A pilot study comparing the
clinical effects of Jia-Wey Shiau-Yau San, a traditional
Chinese herbal prescription, and a continuous combined
hormone replacement therapy in postmenopausal
women with climacteric symptoms. Maturitas 44: 5562.
10. Pao, K. Y. and Chang, H. 1998. Treatment of
menopausal syndrome with Chia-wei-hsiao-yao-san.
Chin. Herbal Treat. 6: 40.
11. LU, X. C. 1998. Clinical applications of Kuei-lu-erhhsien-chiao. Messages Chin. Med. 11: 36-37.
12. Chen, X. Z., Yan, D. F. and Yan, H. C. 1996. Treatment
of hollow vertebrae. Jilin. Chin. Med. 2: 29-30.
13. Wang, T. F. 1994. Treatment of menstrual pain in 25
cases with Kuei-lu-erh-hsien-chiao. Chin. Agric. Med.
11: 698-699.
14. Ma, P. L. 1997. Clinical observations of 36 cases of
infertility treated by acupunture and Chinese medicine.
Jiangxi Chin. Med. 4: 35-36.
15. Matsumoto, C., Kushida, K., Yamazaki, K., Imose, K.
and Inoue, T. 1994. Metacarpal bone mass in normal
and osteoporotic Japanese women using computed Xray densitometry. Calcif. Tissue Int. 55: 324-329.
16. Uusi-Rasi, K., Sievanen, H., Vuori, I., Heinonen, A.,
Kannus, P., Pasanen, M., Rinne, M. and Oja, P. 1999.
Long-term recreational gymnastics, estrogen use, and
selected risk factors for osteoporotic fractures. J. Bone
Miner. Res. 14: 1231-1238.
17. Chailurkit, L. O., Ongphiphadhanakul, B., Piaseu, N.,
Saetung, S. and Rajatanavin, R. 2001. Biochemical
markers of bone turnover and response of bone mineral
density to intervention in early postmenopausal women:
an experience in a clinical laboratory. Clin. Chem. 47:
1083-1088.
18. Jones, G., Beard, T., Parameswaran, V., Greenaway, T.
and Von Witt, R. 1997. A population-based study of the
relationship between salt intake, bone resorption and
bone mass. Eur. J. Clin. Nutr. 51: 561-565.

238
Journal of Food and Drug Analysis, Vol. 13, No. 3, 2005

19. Payer, J. Jr., Killinger, Z., Masaryk, P., Tomkova, S.,
Kmecova, Z., Ondrejkova, J., Necas, L., Smoterova, J.,
Ondrejka, P. and Kratochvilova, H. 2000. Effect of
alendronate therapy on bone turnover-results of a multicenter study. Vnitr. Lek. 46: 689-692.
20. Chun, S. 1997. Yi-Fang-Ji-Jie. 3rd ed. pp. 26-27, 173174. Zhi-Yuan publisher. Taiwan.
21. Waynforth, H. B. and Flecknell, P. A. 1992.
Experimental and Surgical Technique in the Rat. pp.
276-278. Academic Press. San Diego, U. S. A.
22. Lewis, D. B., Liggitt, H. D., Effmann, E. L., Motley, S.
T., Teitelbaum, S. L., Jepsen, K. L., Goldstein, S. A.,
Bonadio, J., Carpenter, J. and Perlmutter, R. M. 1993.
Osteoporosis induced in mice by overproduction of
interleukin 4. Proc. Natl. Acad. Sci. 90: 11618-11622.
23. Hidaka, S., Okamoto, Y., Nakajima, K., Suekawa, M.
and Liu, S. Y. 1997. Preventive effects of traditional
Chinese (Kampo) medicines on experimental osteoporosis induced by Ovariectomy in rats. Calcif. Tissue
Int. 61: 239-246.
24. Picard, F., Deshaies, Y., Lalonde, J., Samson, P., Labrie,
C., Belanger, A., Labrie, F. and Richard, D. 2000.
Effects of the estrogen antagonist EM-652.HCl on
energy balance and lipid metabolism in ovariectomized
rats. Int. J. Obes. Relat. Metab. Disord. 24: 830-840.
25. Roudebush, R. E., Magee, D. E., Bensley, D. N.,
Bendele, A. M. and Bryant, H. U. 1993. Effect of
weight manipulation on bone loss due to ovariectomy
and protective effects of estrogrn in the rats. Calcif.
Tissue Int. 53: 61-64.
26. Yamaguchi, K., Shinohara, C., Kojima, S., Sodeoka, M.
and Tsuji, T. 1999. (2E, 6R)-8-hydroxy-2,6-dimethyl-2octenoic acid, a novel anti-osteoporotic monoterpene,
isolated from Cistanche salsa. Biosci. Biotechnol.
Biochem. 63: 731-735.
27. Hidaka, S., Okamoto, Y., Yamada, Y., Kon, Y. and
Kimura, T. 1999. A Japanese herbal medicine, Chujoto, has a beneficial effect on osteoporosis in rats.
Phytother. Res. 13: 14-19.

28. Panin, N., Gorday, W. J. and Paul, B. J. 1971.
Osteoporosis in hemipiegia. Stroke 2: 41-47.
29. Jakubas-Przewlocka, J., Sawicki, A. and Przewlocki, P.
2003. Assessment of trabecular bone structure in postmenopausal and senile osteoporosis in women by image
analysis. Scand. J. Rheumatol. 32: 295-299.
30. Young, D. R., Niklowitz, W. J. and Steele, C. R. 1983.
Tibial changes in experimental disuse osteoporosis in
the monkey. Calcif. Tissue Int. 35: 304-308.
31. Gala, J., Diaz-Curiel, M., de la Piedra, C. and Calero, J.
2001. Short- and long-term effects of calcium and
exercise on bone mineral density in ovariectomized
rats. Br. J. Nutr. 86: 521-527.
32. Nawawi, H. M., Yazid, T. N., Ismail, N. M., Mohamad,
A. R., Nirwana, S. I. and Khalid, B. A. 2001. Serum
bone specific alkaline phosphatase and urinary
deoxypyridinoline in postmenopausal osteoporosis.
Malays J. Pathol. 23: 79-88.
33. Wronski, T. J., Cintron, M. and Dann, L. M. 1988.
Temporal relationship between bone loss and increased
bone turnover in ovariectomized rats. Calcif. Tissue Int.
43: 179-183.
34. Melton, L. J., Khosla, S., Atkinson, E. J., O’Fallon, W.
M. and Riggs, B. L. 1997. Relationship of bone
turnover to bone density and fractures. J. Bone Miner.
Res. 12: 1083-1091.
35. Parviainen, M. T., Jasakelainen, K., Kroger, H., Amala,
I. and Alhava, E. 1999. Urinary bone resorption
markers in monitoring treatment of symptomatic osteoporosis. Clin. Chim. Acta 279: 145-154.
36. Frolik, C. A., Bryant, H. U., Black, E. C., Magge, D. E.
and Chandrasekhar, S. 1996. Time-dependent changes
in biochemical bone markers and serum cholesterol in
ovariectomized rats: efffects of raloxifene HCL,
tamoxifen, estrogen and alendronate. Bone 18: 621-627.
37. Swaminathan, R. 2001. Biochemical markers of bone
turnover. Clin. Chim. Acta 313: 95-105.

